Life ScienceCompany
SERB Pharmaceuticals M&A Summary
SERB Pharmaceuticals has acquired 2 companies of its own, including 2 in the last 5 years.
SERB Pharmaceuticals’ largest acquisition to date was in 2020, when it acquired BTG Specialty Pharmaceuticals for $800M. SERB Pharmaceuticals has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).
SERB Pharmaceuticals Ownership
Who owns SERB Pharmaceuticals?
SERB Pharmaceuticals is owned by Charterhouse Capital Partners and Merieux Equity Partners. It was acquired on June 9, 2017.
Is SERB Pharmaceuticals PE-backed?
Yes. SERB Pharmaceuticals is owned by private equity investors Charterhouse Capital Partners and Merieux Equity Partners.
SERB Pharmaceuticals Business Overview
Where is SERB Pharmaceuticals headquartered?
SERB Pharmaceuticals is headquartered in Luxembourg, Luxembourg.
What sector is SERB Pharmaceuticals in?
SERB Pharmaceuticals is a life science company.
When was SERB Pharmaceuticals founded?
SERB Pharmaceuticals was founded in 1951.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
Unlimited Searches
